ClinDev

Analysis, Insight & Engagement for Clinical Development

Skip to content
  • Home
  • Latest news
  • Features
    • Interviews
    • Humour
  • Calendar
  • Jobs
  • Contact/Advertise
    • Donate
    • CV
ClinDev

Latest items

  • US government outlines “Precision Medicine” plans
  • ICON creates new innovation hub in Ireland
  • Chugai to launch translational research division
  • FDA announces intended guidance topics for 2015
  • CHMP recommends medicines be suspended after CRO inspection
  • EMA launches consultation on transparency & Clinical Trials Regulation
  • Clinipace set for new wave of CRO M&A activity
  • Report highlights rising levels of investigator turnover & protocol noncompliance
  • US Institute of Medicine backs clinical data transparency
  • EMA clinical data publication policy comes into force

Most read

  • Dianthus calls it a day
  • Survey shows CROs focus on base salaries, staff turnover increasing outside US
  • ICON to acquire Aptiv Solutions
  • US Clinical Research Forum announces award-winning research projects
  • FDA issues guidance on bioequivalence studies with pharmacokinetic endpoints
  • Alison Messom on the ICR Chairman's Forum: Focus on Metrics
  • …
  • FDA finalises guidance on qualified drug development tools
  • WMA opens public consultation on revisions to Declaration of Helsinki
  • FDA finalises guidance on electronic source data in clinical trials

Subscribe! Free email bulletin

* = required field

Browse by topic

AbbVie AstraZeneca Clinical trial data Conference corporate CRO data protection Declaration of Helsinki eclinical EFPIA EMA Ethics Europe FDA GSK Guidance Health Research Authority ICR Forum India informed consent Intellectual property IPO M&A MAA applications MHRA NHS NIHR Novartis Oncology Partnership Patient recruitment pharmacovigilance Quintiles R&D Regulation Research ethics Risk-adaptive monitoring Risk-based approach Roche Select committee Survey transparency UK USA webinar
Proudly powered by WordPress